The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death

with No hi ha comentaris
  • Mateja, A., Chu, E., Murray, T., Bramante, C., Moser, C., Givens, N.,…Potter, G. (2025a). The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf282 (En premsa)

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *